Cargando…

Comparison of a preservative-free nonsteroidal anti-inflammatory drug and preservative-free corticosteroid after uneventful cataract surgery: multicenter, randomized, evaluator-blinded clinical trial

To compare the efficacy of nonsteroidal anti-inflammatory drugs (NSAIDs) and steroidal eyedrops for inflammation management after cataract surgery using slitlamp indicators. SETTING: 11 eye centers in South Korea. DESIGN: Randomized prospective multicenter study with a blinded evaluator. METHOD: In...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Seonjoo, Ko, Byung-Yi, Koh, Jae Woong, Kim, Eun Chul, Kim, Hong Kyun, Shin, Young Joo, Song, Jong-Suk, Lee, Do Hyung, Lee, Ji Eun, Lee, Hyung Keun, Chung, So-Hyang, Kim, Hyun Seung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119399/
https://www.ncbi.nlm.nih.gov/pubmed/34629379
http://dx.doi.org/10.1097/j.jcrs.0000000000000841
_version_ 1784710693722783744
author Kim, Seonjoo
Ko, Byung-Yi
Koh, Jae Woong
Kim, Eun Chul
Kim, Hong Kyun
Shin, Young Joo
Song, Jong-Suk
Lee, Do Hyung
Lee, Ji Eun
Lee, Hyung Keun
Chung, So-Hyang
Kim, Hyun Seung
author_facet Kim, Seonjoo
Ko, Byung-Yi
Koh, Jae Woong
Kim, Eun Chul
Kim, Hong Kyun
Shin, Young Joo
Song, Jong-Suk
Lee, Do Hyung
Lee, Ji Eun
Lee, Hyung Keun
Chung, So-Hyang
Kim, Hyun Seung
author_sort Kim, Seonjoo
collection PubMed
description To compare the efficacy of nonsteroidal anti-inflammatory drugs (NSAIDs) and steroidal eyedrops for inflammation management after cataract surgery using slitlamp indicators. SETTING: 11 eye centers in South Korea. DESIGN: Randomized prospective multicenter study with a blinded evaluator. METHOD: In 125 (250 eyes) patients who underwent cataract surgery, bromfenac sodium hydrate 0.1% (NSAID group) was applied twice a day in 1 eye, whereas the other eye was treated with fluorometholone 0.1% (steroid group), 4 times a day for 4 weeks postoperatively. The primary efficacy outcome was the presence of anterior chamber cells and flare at 1 week postoperatively. Anterior chamber cells and flare at 4 to 8 weeks, corrected distance visual acuity, central corneal thickness, conjunctival hyperemia, dry eye parameters, foveal thickness, and ocular and visual discomfort were evaluated as secondary outcomes. RESULTS: At week 1, residual anterior chamber inflammation was not statistically significantly different between the groups (−1.03 ± 1.27 vs −0.95 ± 1.24, P = .4850). However, the NSAID group recovered from conjunctival hyperemia more rapidly than the steroid group (0.30 ± 0.52 vs 0.44 ± 0.81, P = .0144 at week 1). The increase in central corneal thickness in the NSAID group was less than that in the steroid group 1 week postoperatively (7.87 ± 22.46 vs 29.47 ± 46.60 μm, P < .0001). The change in foveal thickness in the NSAID group was significantly less than that in the steroid group (18.11 ± 68.19 vs 22.25 ± 42.37 μm, P = .0002). Lower levels of postoperative ocular and visual discomfort were reported in the NSAID group than in the steroid group under treatment. CONCLUSIONS: Preservative-free bromfenac was as effective as preservative-free fluorometholone eyedrops in anterior chamber inflammation control and showed better signs and symptoms after cataract surgery.
format Online
Article
Text
id pubmed-9119399
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer
record_format MEDLINE/PubMed
spelling pubmed-91193992022-05-25 Comparison of a preservative-free nonsteroidal anti-inflammatory drug and preservative-free corticosteroid after uneventful cataract surgery: multicenter, randomized, evaluator-blinded clinical trial Kim, Seonjoo Ko, Byung-Yi Koh, Jae Woong Kim, Eun Chul Kim, Hong Kyun Shin, Young Joo Song, Jong-Suk Lee, Do Hyung Lee, Ji Eun Lee, Hyung Keun Chung, So-Hyang Kim, Hyun Seung J Cataract Refract Surg Article To compare the efficacy of nonsteroidal anti-inflammatory drugs (NSAIDs) and steroidal eyedrops for inflammation management after cataract surgery using slitlamp indicators. SETTING: 11 eye centers in South Korea. DESIGN: Randomized prospective multicenter study with a blinded evaluator. METHOD: In 125 (250 eyes) patients who underwent cataract surgery, bromfenac sodium hydrate 0.1% (NSAID group) was applied twice a day in 1 eye, whereas the other eye was treated with fluorometholone 0.1% (steroid group), 4 times a day for 4 weeks postoperatively. The primary efficacy outcome was the presence of anterior chamber cells and flare at 1 week postoperatively. Anterior chamber cells and flare at 4 to 8 weeks, corrected distance visual acuity, central corneal thickness, conjunctival hyperemia, dry eye parameters, foveal thickness, and ocular and visual discomfort were evaluated as secondary outcomes. RESULTS: At week 1, residual anterior chamber inflammation was not statistically significantly different between the groups (−1.03 ± 1.27 vs −0.95 ± 1.24, P = .4850). However, the NSAID group recovered from conjunctival hyperemia more rapidly than the steroid group (0.30 ± 0.52 vs 0.44 ± 0.81, P = .0144 at week 1). The increase in central corneal thickness in the NSAID group was less than that in the steroid group 1 week postoperatively (7.87 ± 22.46 vs 29.47 ± 46.60 μm, P < .0001). The change in foveal thickness in the NSAID group was significantly less than that in the steroid group (18.11 ± 68.19 vs 22.25 ± 42.37 μm, P = .0002). Lower levels of postoperative ocular and visual discomfort were reported in the NSAID group than in the steroid group under treatment. CONCLUSIONS: Preservative-free bromfenac was as effective as preservative-free fluorometholone eyedrops in anterior chamber inflammation control and showed better signs and symptoms after cataract surgery. Wolters Kluwer 2022-06 2021-10-08 /pmc/articles/PMC9119399/ /pubmed/34629379 http://dx.doi.org/10.1097/j.jcrs.0000000000000841 Text en Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of ASCRS and ESCRS https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Article
Kim, Seonjoo
Ko, Byung-Yi
Koh, Jae Woong
Kim, Eun Chul
Kim, Hong Kyun
Shin, Young Joo
Song, Jong-Suk
Lee, Do Hyung
Lee, Ji Eun
Lee, Hyung Keun
Chung, So-Hyang
Kim, Hyun Seung
Comparison of a preservative-free nonsteroidal anti-inflammatory drug and preservative-free corticosteroid after uneventful cataract surgery: multicenter, randomized, evaluator-blinded clinical trial
title Comparison of a preservative-free nonsteroidal anti-inflammatory drug and preservative-free corticosteroid after uneventful cataract surgery: multicenter, randomized, evaluator-blinded clinical trial
title_full Comparison of a preservative-free nonsteroidal anti-inflammatory drug and preservative-free corticosteroid after uneventful cataract surgery: multicenter, randomized, evaluator-blinded clinical trial
title_fullStr Comparison of a preservative-free nonsteroidal anti-inflammatory drug and preservative-free corticosteroid after uneventful cataract surgery: multicenter, randomized, evaluator-blinded clinical trial
title_full_unstemmed Comparison of a preservative-free nonsteroidal anti-inflammatory drug and preservative-free corticosteroid after uneventful cataract surgery: multicenter, randomized, evaluator-blinded clinical trial
title_short Comparison of a preservative-free nonsteroidal anti-inflammatory drug and preservative-free corticosteroid after uneventful cataract surgery: multicenter, randomized, evaluator-blinded clinical trial
title_sort comparison of a preservative-free nonsteroidal anti-inflammatory drug and preservative-free corticosteroid after uneventful cataract surgery: multicenter, randomized, evaluator-blinded clinical trial
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119399/
https://www.ncbi.nlm.nih.gov/pubmed/34629379
http://dx.doi.org/10.1097/j.jcrs.0000000000000841
work_keys_str_mv AT kimseonjoo comparisonofapreservativefreenonsteroidalantiinflammatorydrugandpreservativefreecorticosteroidafteruneventfulcataractsurgerymulticenterrandomizedevaluatorblindedclinicaltrial
AT kobyungyi comparisonofapreservativefreenonsteroidalantiinflammatorydrugandpreservativefreecorticosteroidafteruneventfulcataractsurgerymulticenterrandomizedevaluatorblindedclinicaltrial
AT kohjaewoong comparisonofapreservativefreenonsteroidalantiinflammatorydrugandpreservativefreecorticosteroidafteruneventfulcataractsurgerymulticenterrandomizedevaluatorblindedclinicaltrial
AT kimeunchul comparisonofapreservativefreenonsteroidalantiinflammatorydrugandpreservativefreecorticosteroidafteruneventfulcataractsurgerymulticenterrandomizedevaluatorblindedclinicaltrial
AT kimhongkyun comparisonofapreservativefreenonsteroidalantiinflammatorydrugandpreservativefreecorticosteroidafteruneventfulcataractsurgerymulticenterrandomizedevaluatorblindedclinicaltrial
AT shinyoungjoo comparisonofapreservativefreenonsteroidalantiinflammatorydrugandpreservativefreecorticosteroidafteruneventfulcataractsurgerymulticenterrandomizedevaluatorblindedclinicaltrial
AT songjongsuk comparisonofapreservativefreenonsteroidalantiinflammatorydrugandpreservativefreecorticosteroidafteruneventfulcataractsurgerymulticenterrandomizedevaluatorblindedclinicaltrial
AT leedohyung comparisonofapreservativefreenonsteroidalantiinflammatorydrugandpreservativefreecorticosteroidafteruneventfulcataractsurgerymulticenterrandomizedevaluatorblindedclinicaltrial
AT leejieun comparisonofapreservativefreenonsteroidalantiinflammatorydrugandpreservativefreecorticosteroidafteruneventfulcataractsurgerymulticenterrandomizedevaluatorblindedclinicaltrial
AT leehyungkeun comparisonofapreservativefreenonsteroidalantiinflammatorydrugandpreservativefreecorticosteroidafteruneventfulcataractsurgerymulticenterrandomizedevaluatorblindedclinicaltrial
AT chungsohyang comparisonofapreservativefreenonsteroidalantiinflammatorydrugandpreservativefreecorticosteroidafteruneventfulcataractsurgerymulticenterrandomizedevaluatorblindedclinicaltrial
AT kimhyunseung comparisonofapreservativefreenonsteroidalantiinflammatorydrugandpreservativefreecorticosteroidafteruneventfulcataractsurgerymulticenterrandomizedevaluatorblindedclinicaltrial